Are inflammation-related diseases risk factors for primary acquired nasolacrimal duct obstruction? A large scale, national case-control study-Reference-Cited by-同舟云学术

Are inflammation-related diseases risk factors for primary acquired nasolacrimal duct obstruction? A large scale, national case-control study

Published:2024-01-09 Issue:6 Volume:262 Page:1911-1917
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Kerber Lior^ORCID,Kerman Tomer,Hazan Itai,Ziv Oren,Kordelul Sofia,Tsumi Erez

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00417-023-06352-2.pdf

Reference29 articles.

1. Woog JJ (2007) The incidence of symptomatic acquired lacrimal outflow obstruction among residents of Olmsted County, Minnesota, 1976-2000 (an American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc 105:649–666

2. Das AV, Rath S, Naik MN, Ali MJ (2019) The incidence of lacrimal drainage disorders across a tertiary eye care network: customization of an indigenously developed electronic medical record system-EyeSmart. Ophthalmic Plast Reconstr Surg 35:354–356. https://doi.org/10.1097/IOP.0000000000001257

3. Schaefer DP (2015) Acquired etiologies of lacrimal system obstructions. In: The Lacrimal System: Diagnosis, Management, and Surgery, pp 42–68. https://doi.org/10.1007/978-3-319-10332-7_5

4. Ali MJ (2023) Etiopathogenesis of primary acquired nasolacrimal duct obstruction. Prog Retin Eye Res 96. https://doi.org/10.1016/j.preteyeres.2023.101193

5. Alessio G, Boscia F, La Tegola MG, Sborgia C (2001) Clinicopathologic analysis of 166 patients with primary acquired nasolacrimal duct obstruction. Ophthalmology 108:2038–2040. https://doi.org/10.1016/s0161-6420(01)00783-7